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Protein disulfide isomerase plays a key role
in catalyzing the folding of secretory pro-
teins. It features two catalytically inactive
thioredoxin domains inserted between two
catalytically active thioredoxin domains
and an acidic C-terminal tail. The crystal
structure of yeast PDI reveals that the four
thioredoxin domains are arranged in the
shape of a twisted ‘‘U’’ with the active sites
facing each other across the long sides of
the ‘‘U.’’ The inside surface of the ‘‘U’’ is en-
riched in hydrophobic residues, thereby
facilitating interactions with misfolded pro-
teins. The domain arrangement, active site
location, and surface features strikingly
resemble the Escherichia coli DsbC and
DsbG protein disulfide isomerases. Bio-
chemical studies demonstrate that all do-
mains of PDI, including the C-terminal tail,
are required for full catalytic activity. The
structure defines a framework for rationaliz-
ing the differences between the two active
sites and their respective roles in catalyzing
the formation and rearrangement of disul-
fide bonds.
INTRODUCTION
The tertiary structure of many proteins is stabilized by intra-
molecular disulfide bonds. Ever since the discovery of pro-
tein disulfide isomerase (PDI) by Anfinsen over 40 years
ago (Goldberger et al., 1964), PDI has been extensively stud-ied as a key enzyme involved in the formation of the correct
pattern of disulfide bonds in proteins. PDI is an abundant
protein that is primarily located in the lumen of the endoplas-
mic reticulum (ER) and is found in all eukaryotic cells (re-
viewed in Wilkinson and Gilbert, 2004). It contains two active
sites that mediate the formation and rearrangement of pro-
tein disulfide bonds. The domain architecture of mammalian
PDI (Figure 1A) as determined by limited proteolysis (Freed-
man et al., 1998) reveals four domains, a, b, b0, and a0, fol-
lowed by a C-terminal extension (referred to as c) that har-
bors the ER-retention signal. The a and a0 domains each
contain one catalytically active C-G-H-C motif (Figure 1B),
while the b and b0 domains are redox inactive. There are sev-
eral PDI paralogs in humans (Ellgaard and Ruddock, 2005)
and to a lesser extent also in yeast (Norgaard et al., 2001),
but their detailed roles and specificities have not been de-
scribed.
PDI is a multifunctional protein that, besides its ability to in-
troduce and isomerize disulfide bonds, also acts as a chap-
erone that can facilitate the folding of proteins devoid of di-
sulfide bonds (Wang and Tsou, 1993). Recently, PDI from
Caenorhabditis elegans was shown to display transglutami-
nase activity (Natsuka et al., 2001). In addition, PDI consti-
tutes the noncatalytic subunit of prolyl 4-hydroxylase (Koivu
et al., 1987) and microsomal triglyceride transfer protein
(Wetterau et al., 1990). Its presence in the nucleus and on
the cell surface (reviewed by Turano et al., 2002) suggests
that PDI may have additional functions. The flavoprotein
Ero1 (Frand and Kaiser, 1998; Pollard et al., 1998) transfers
oxidizing equivalents to PDI, which in turn transfers them to
newly synthesized polypeptides leading to the de novo for-
mation of disulfide bonds.
Despite extensive efforts in many laboratories to under-
stand PDI’s functions, utilizing the mammalian and yeast en-
zymes (reviewed in Ellgaard and Ruddock, 2005; Wilkinson
and Gilbert, 2004), it became apparent that further progress
required knowledge of its three-dimensional structure at
high resolution. Two crystallization studies of the N-terminal
half of human PDI (Wang et al., 1999) and microsomalCell 124, 61–73, January 13, 2006 ª2006 Elsevier Inc. 61
Figure 1. Primary Structure of Mammalian and Yeast PDI
(A) Domain organization of bovine PDI as deduced from biochemical studies and that of yeast PDI based on the crystal structure (c represents the C-terminal
tail). The C-G-H-C motifs indicate the location of the active sites, the Cs the nonactive site cysteines, and x the loop connecting the b0 and a0 domains.
(B) Multiple sequence alignment of yeast and mammalian PDIs. Helices and strands are represented by cylinders and arrows, respectively. Active-site res-
idues in the a and a0 domain are boxed. Black arrows highlight the two buried polar residues in the vicinity of the active site, white arrows the nonactive site
cysteines, and blue arrows the cis-prolines near each active site. Boxed residues in the b0 domain form a hydrophobic pocket presumably involved in sub-
strate binding. The bar above the sequence represents the domain architecture.triglyceride transfer protein (Ohringer et al., 1996) have been
published, but in neither case was a structure reported. In
the meantime, structures of the individual a and b domains
of human PDI have been determined by NMR spectroscopy
(Kemmink et al., 1996, 1997). These studies revealed that
not only the a domain but also the b domain adopts the thi-
oredoxin fold. Based on sequence similarities between the
a and a0 domains and the b and b0 domains, respectively,62 Cell 124, 61–73, January 13, 2006 ª2006 Elsevier Inc.the structure of PDI was predicted to be composed of four
thioredoxin domains (reviewed in Ellgaard and Ruddock,
2005), of which two are catalytically active and two are inac-
tive. However, the three-dimensional arrangement of the
four thioredoxin domains and their respective roles in the
catalytic mechanism were still unknown. In this study, we de-
scribe the crystal structure of full-length yeast PDI at 2.4 A˚
resolution, the first complete PDI structure. Structure-based
site-directed mutagenesis studies at the level of entire do-
mains and individual residues were utilized in order to begin
to understand the relationship between the three-dimen-
sional structure of the enzyme and its catalytic properties.
RESULTS AND DISCUSSION
Overall Architecture and Thioredoxin Folds
Residues 23–522 of the yeast PDI1 gene were cloned into
the intein vector pTYB12, which incorporates a tetrapeptide
at the N terminus of PDI. The refined model contains 483 out
of 504 residues present in the construct, with 3 N-terminal
residues of the vector-derived tetrapeptide and 18 residues
at the C terminus not visible in the electron density maps,
presumably due to disorder. The residue numbers were as-
signed according to their original number in the PDI1 gene,
with the last residue of the tetrapeptide, a Met, numbered
22. The model has been refined at 2.4 A˚ resolution to an R
factor of 0.191 (Rfree = 0.247) with very good stereochemistry
(Table 1). According to a PROCHECK analysis (Laskowski
et al., 1993), 99% of the residues are in the most favored
and additionally allowed regions of the Ramachandran dia-
gram, with A361 and S464 in generously allowed and the
weakly defined residue, N373, in disallowed regions.
The overall structure of PDI adopts the shape of the letter
‘‘U,’’ albeit in twisted form, with the a and a0 domains on the
ends of the ‘‘U’’ and the b and b0 domains forming the base
(Figure 2A). The dimensions of the molecule are 80 A˚ for
the width and 60 A˚ for the height of the ‘‘U.’’ Each of the
a, a0, b, and b0 domains adopts the thioredoxin fold with mi-
nor variations (Figure 2B). The prototypical thioredoxin fold is
composed of a five-stranded central b sheet decorated with
two a helices on either side (Figure 2C). The secondary
structure elements are arranged in the order babababba,
with the two longer a helices grouped together on the
same side of the b sheet. The a and a0 domains both adopt
a canonical thioredoxin fold. Although the secondary struc-
ture assignment with PROMOTIF does not recognize b5 in
the a0 domain, an equivalent stretch of residues (461–468)
is present, but its structure is somewhat irregular and pre-
vents the formation of a standard hydrogen-bonding pattern.
The a and a0 domains each contain an active site, which is
characterized by the C-G-H-C consensus sequence located
at the N terminus of the second a helix. This is the longest
helix and extends from one end of the b sheet to the other.
To facilitate this, a highly conserved proline in the a and
a0 domains introduces a kink in the first half of this helix.
The b and b0 domains both display minor variations from
the typical thioredoxin fold. For example, the b domain
does not contain the third a helix, and its second helix is con-
siderably shorter, whereas the b0 domain features an addi-
tional short helix prior to the last helix and does not contain
the first b strand. The centers of gravity of the four thiore-
doxin-like domains are not in the same plane. In the orienta-
tion shown in the lower panel of Figure 2A, the a, b0, and
a0 domains are in the plane perpendicular to the page, with
the b domain being displaced upward. As a consequence
of this asymmetry, the a domain is in contact with both theTable 1. Data Collection and Refinement Statistics
Data Collection
Statistics
Space group I4
Unit cell dimensions (A˚) a = b = 136.9 and
c = 70.1
Unique reflections 24,847
Resolution limits (A˚) 50–2.4
Completeness (highest
shell)
0.987 (0.967)
Redundancy 6.4 (2.9)
Rsym (highest shell) 0.063 (0.632)
<I/sI> (highest shell) 42.1 (3.2)
Refinement Statistics
Resolution limits 20–2.4
Number of working/
test reflections
23,557/1,246
Number of protein/
solvent atoms
3,821/152
Wilson B factor (A˚2) 65.4
Overall average B
factor (A˚2)
91.0
(individual domains:
a/b/b0/a0/c)
(75.7/64.0/78.0/99.3/
134.5)
R factor (Rfree) 0.191 (0.247)
Data precision index (A˚) 0.33
RMS deviations from
ideal values in
Bond lengths (A˚) 0.017
Bond angles (º) 1.63
Torsion angles (º) 8.3/37.9/18.1
Planar groups (A˚) 0.006/0.008
Ramachandran
statistics
0.901/0.092/
0.005/0.002
Rsym =
P
hkl
P
ijIi  <I>j/
P
hkl
P
iIi, where Ii is the i
th measurement
and <I> is the weighted mean of all measurements of I (no sigma
cutoffs were applied). <I/sI> indicates the average of the inten-
sity divided by its standard deviation. Numbers in parentheses
refer to the respective highest-resolution data shell in each data-
set. Rcryst =
P
hklkFoj – jFck/
P
hkljFoj, where Fo and Fc are the ob-
served and calculated structure factor amplitudes (no sigma cut-
offs were applied). Rfree is the same as Rcryst for 5% of the data
randomly omitted from refinement. The data precision index is
based on the free R factor as calculated by REFMAC. Torsion
angles specify planar/staggered/orthonormal angles, respec-
tively, and values for planar groups are for peptide and aromatic
planes. Ramachandran statistics indicate the fraction of residues
in the most favored, additionally allowed, generously allowed,
and disallowed regions of the Ramachandran diagram as de-
fined by PROCHECK.Cell 124, 61–73, January 13, 2006 ª2006 Elsevier Inc. 63
Figure 2. Overall Structure of PDI
(A) Ribbon diagram of PDI with the a, b, b0, and a0 domains in magenta, cyan, yellow, and red, respectively, and the C-terminal extension in green. The two
orientations roughly differ by a 90º rotation around the horizontal axis. The side chains of the active site cysteines in the a and a0 domains are shown in space-
filling representation with the sulfur atoms in yellow.
(B) Structural comparison of the individual domains of PDI. The domains are shown in the same relative orientation, with the ‘‘long helix’’ side below the
b sheet. The active-site cysteine residues in the a and a0 domains are shown in space-filling representation.
(C) Secondary structure diagram of the canonical thioredoxin fold with a helices in green and b strands in red. The location of the active site is indicated by
a red oval.b and b0 domains, while the a0 domain only interacts with the
b0 domain. The active sites in the a and a0 domains point at
each other, but are separated by a large cleft (see below). Fi-
nally, the C-terminal extension is on the opposite side of the
interface between the b0 and a0 domains.
The connections between the a and b domains as well as
the b and b0 domains in PDI are short. However, the connec-
tion between the b0 and a0 domains is comprised of 17 res-
idues that are mostly in extended conformation and span
a distance of 43 A˚. These residues correspond to the seg-
ment labeled x in Figure 1A. This loop has been predicted to
exist in mammalian PDI (Freedman et al., 1998) and has sub-
sequently been referred to as loop ‘‘x’’ (Pirneskoski et al.,
2004). The interface between the b and b0 domains is some-
what extensive, with a buried surface area of 700 A˚2. In
contrast, the interfaces between the a and b domains and
the b0 and a0 domains are negligibly small, with buried sur-
face areas of only 200 A˚2. These data suggest that the64 Cell 124, 61–73, January 13, 2006 ª2006 Elsevier Inc.a and a0 domains are flexible with respect to a more rigid
base formed by the b and b0 domains and could adopt the
elongated conformation determined by analytical ultracentri-
fugation for rat PDI (Solovyov and Gilbert, 2004).
The C-Terminal Tail
A significant fraction (residues 486–504) of the C-terminal
extension, which is composed primarily of negatively
charged residues (16 Asp/Glu in the range from 486–522),
was found to be ordered. Residues 490–502 form an a helix,
a somewhat surprising finding, because secondary structure
predictions assign this region as random coil. The C-terminal
tail is located opposite the active site in the a0 domain, which
seems to argue against its direct involvement in the catalytic
activity of PDI. However, when the activity of the PDI
C-terminal deletion construct (Figure 3, line 5) was tested
for both refolding of scrambled ribonuclease (sRNase) and
reduced ribonuclease (rRNase), it exhibited about half the
Figure 3. Functional Characterization of
PDI
In vitro PDI activity assay using scrambled ribo-
nuclease (sRNase) and reduced ribonuclease
(rRNase) as substrates. The domain boundaries
of the deletion constructs are defined in Figure 1A
and * indicate the relative location of the altered
residues. The standard deviations are derived
from three independent experiments.activity of full-length PDI, i.e., 59% for sRNase and 41% for
rRNase. Because the first turn of the C-terminal helix is en-
gaged in hydrophobic interactions with the a0 domain, we
speculated that the C-terminal helix stabilizes the structure
of the a0 domain, which would be in agreement with the ob-
served low stability of the isolated a0 domain of mammalian
PDI (Darby and Creighton, 1995b).
Based on this assumption, two more C-terminal trunca-
tions were prepared: PDI-DC28, ending after the first turn
of the helix; and PDI-DC18, leaving the entire helix intact.
The assays reveal (Figure 3, lines 3–5) that the activity in-
creases as fewer residues are truncated, which is consistent
with the idea that hydrophobic interactions between the helix
and the a0 domain are important for PDI’s activity. However,
leaving the helix intact in the C-terminal domain does not
completely restore activity equal to the full-length enzyme,
with 83% and 87% in the sRNase and rRNase assay, re-
spectively, for the PDI-DC18 variant. These data suggest
that the C-terminal residues play an important role in the ac-
tivity of yeast PDI. Whether the C-terminal helix is present in
mammalian PDI is difficult to predict, because the C-terminal
domains share low sequence identity between yeast and
mammalian PDI.
Surface Properties
Although PDI is a soluble protein located in the ER lumen, the
structure of PDI shows several patches of surface-exposed
hydrophobic residues, two of which surround the active sites
in the a and a0 domains. This feature has already been iden-tified in the NMR structure of the a domain of human PDI
(Kemmink et al., 1996) and the DsbA crystal structure (Martin
et al., 1993), where this patch has been proposed to be in-
volved in the interactions with the substrate. Each of the
b and b0 domains of PDI have one exposed hydrophobic
patch at the same relative position, which, together with
the hydrophobic patches surrounding the active sites in
the a and a0 domains, form a continuous hydrophobic sur-
face (Figure 4A). The crystal structure suggests that these
hydrophobic residues are crucial for the interaction between
PDI and its substrates, which are either unfolded or partially
folded proteins containing exposed hydrophobic residues.
The exposed hydrophobic residues could also nicely explain
how PDI acts as a chaperone: aggregation of misfolded pro-
teins via exposed hydrophobic residues could be sup-
pressed by sequestering them in the hydrophobic cleft of
PDI.
The primary substrate binding site has been mapped to
the b0 domain for mammalian PDI (Klappa et al., 1998). Ex-
amination of the b0 domain revealed a highly hydrophobic
pocket made up of residues from the first and third a helix
and the b sheet (Figure 4B). I272 of human PDI has been
identified as crucial for substrate binding (Pirneskoski et al.,
2004), and the corresponding residue in yeast, V291, is lo-
cated at the bottom of this hydrophobic pocket in the
b0 domain. So far, the b domain has been proposed to
play only a structural role; nevertheless, the hydrophobic
patch on the b domain extends the substrate binding site
of the b0 domain to form a larger substrate binding platform,Cell 124, 61–73, January 13, 2006 ª2006 Elsevier Inc. 65
Figure 4. Hydrophobic Surface Features of PDI
(A) Surface representation of PDI color coded ranging from hydrophobic (green) to hydrophilic (gray) according to the normalized consensus hydrophobicity
scale (Eisenberg et al., 1984) of the exposed residues. The orientation is the same as in Figure 2A, lower panel. The lower left and right panels represent the
a and a0 domain, respectively, which were rotated by +60º and 60º as indicated to allow visualization of the face surrounding the active site, highlighted
in red.
(B) Close-up view of the peptide binding pocket in the b0 domain. The orientation is the same as in (A). Residues in the center line the bottom of the hydro-
phobic pocket.
(C) Packing interactions between the b domain of a symmetry-related molecule and PDI. PDI is shown in a surface representation in roughly the same ori-
entation as in Figure 2A, top panel, with the domains in standard color code. The b domain of the symmetry mate (cyan) is located between the a and
a0 domains.which might enhance the catalytic potential of the enzyme. In
the context of the three-dimensional structure, this platform
is located between the two active sites in the a and a0
domains.
To clarify the functional role of the b and b0 domains, two
pairs of progressively truncated variants were assayed for
their refolding activities. For the first pair of mutants, bb0a0c
and b0a0c, a comparison of the activities (Figure 3, lines 6
and 7) shows that deletion of the b domain does not signifi-
cantly influence the rate of refolding of rRNase, but de-
creases the rate of refolding of sRNase from 84% to 60%.
On the other hand, deletion of the b0 domain within another
pair of variants, ab and abb0, significantly slows down the re-
folding rate of sRNase from 58% to 20%, and of rRNase from66 Cell 124, 61–73, January 13, 2006 ª2006 Elsevier Inc.43% to 27% as shown in Figure 3, lines 8 and 9. This result is
in good agreement with similar progressive truncation stud-
ies of mammalian PDI (Darby et al., 1998) that showed the
b0 domain to be more important than the b domain in the re-
folding of rRNase. We therefore conclude that the b0 domain
is generally important for the refolding of proteins, whereas
the b domain might contribute to the refolding rate in se-
lected cases.
Active Sites
The two active sites face each other on the inside of the
U-shaped molecule and are separated by 28 A˚ as measured
between the sulfur atoms of C61 and C406. The opening be-
tween both active sites and the hydrophobic pocket in the
b0 domain is sufficiently large to accommodate a folded pro-
tein of 100 residues. In fact, in the crystal the b domain of
a symmetry-related molecule is inserted into this cleft (Fig-
ure 4C), where it extensively interacts with the a domain. Bo-
vine PDI has originally been described to form a dimer in so-
lution (Lambert and Freedman, 1983); however, more recent
data on rat PDI suggest a Zn-dependent dimerization (Solo-
vyov and Gilbert, 2004). In agreement with the latter studies,
no PDI dimer is present in the crystal; instead, four PDI mol-
ecules form a tetramer around a crystallographic 4-fold axis
of symmetry, but this does not appear to represent a physio-
logical form of the enzyme, as the contact areas are rather
small and the insertion of the b domain into the active site
would in fact inhibit the enzyme.
As in other members of the thioredoxin family, each active
site has the N-terminal cysteine near the N terminus of the
second a helix, which presumably increases its nucleophilic-
ity, and a cis-peptide immediately prior to the fourth b strand
packed closely against the active site cysteines (Figures 5A–
5C). The a and a0 domains of yeast PDI are very similar to
each other and can be superimposed with a root mean
square (rms) deviation of 1.3 A˚ for 98 residues. Despite the
high overall structural similarity, a few significant differences
between the active sites were identified (as described in the
following two sections), which are likely to reflect different
catalytic properties of the a and a0 domains.
Active Site Redox State
The most noteworthy difference between the a and
a0 domains is the redox state of their active site cysteines.
In the a domain, the two cysteines are primarily in the oxi-
dized state, forming a disulfide bridge (Figures 5A and B),
while their counterparts in the a0 domain are in the reduced
state (Figure 5C). The a domain active-site cysteines are
best modeled as a mixture of oxidized and reduced forms,
with occupancies of 0.8 and 0.2, respectively. A similar mix-
ture of redox states was observed for DsbG (Heras et al.,
2004), where the destabilization of the oxidized form has
been attributed to the presence of a threonine residue in
the adjacent cis-proline loop. The a domain of PDI contains
a phenylalanine instead of threonine, arguing against a role
of the threonine in the modulation of the redox potential in
DsbG. However, PDI, like DsbA (Guddat et al., 1997), con-
tains a histidine between the two cysteine residues, and
this residue appears to destabilize the oxidized form, partic-
ularly in the a0 domain, through a histidine-cysteine ion pair.
The observed oxidation states of the catalytic cysteines are
in agreement with previous observations indicating that
yeast PDI has on average 1.4 free sulfhydryl groups per
molecule (Xiao et al., 2004).
During PDI purification, a high concentration of DTT was
utilized to cleave the intein fusion protein, but subsequently
no reducing agents were present with crystallization being
performed under aerobic conditions. Because the observed
redox state differences may result from different rates of air
oxidation, their correlation with the known redox potentials
might be coincidental. Nevertheless, the long time period re-
quired for crystallization suggests that equilibrium has beenestablished. The equilibrium constant (Kox) for the oxidation
of the cysteine pair in each active site by oxidized glutathione
(GSSG) is 17 mM for the a domain and 1 mM for the
a0 domain (Wilkinson et al., 2005). Based on the Nernst
equation, the corresponding standard redox potentials are
188 mV for the a domain and 152 mV for the a0 domain.
These values are similar to human PDI, with very similar Kox
of 1–2 mM and corresponding redox potentials of 175
mV for the a and a0 domains (Lundstrom and Holmgren,
1993). However, they are dramatically different from DsbA,
the strongest oxidant in the thioredoxin family, with a Kox of
80 mM and redox potential of 120 mV (Zapun et al.,
1993), and thioredoxin, the strongest reductant, with a Kox
of 10 M and redox potential of 270 mV (Aslund et al.,
1997; Moore et al., 1964). The intermediate values for yeast
and human PDI reflect their ability to catalyze the oxidization
and reduction of disulfide bonds. For yeast PDI, these values
predict that the a domain is more stable in the oxidized form,
while the a0 domain prefers to be in the reduced form, in
good agreement with the structure. The redox state of the
a0 domain is further confirmed by the observation that it is se-
lectively oxidized by Ero1 (Tsai and Rapoport, 2002). The
a domain contains two additional cysteines, C90 and C97,
which also form a disulfide bond (Figure 5B). This bond is be-
lieved to destabilize the oxidized state of the active-site cys-
teines, as demonstrated by biochemical studies (Wilkinson
et al., 2005).
Most of the residues in spatial proximity to the catalytically
active site cysteines are either identical or at least type con-
served (Figure 1B). Among them, H64 and R126 in the a do-
main (H408 and R471 in the a0 domain) were previously
demonstrated to be involved in regulating the active-site re-
dox potential (Debarbieux and Beckwith, 2000; Lappi et al.,
2004). At variance with the conservation, E55 and Q87 in the
a domain are replaced by L400 and K434 in the a0 domain,
respectively (Figures 5B and 5C). The side chain of E55 is
in the hydrophobic core of the a domain and is engaged in
a single hydrogen bond with Q87, which in turn forms two
hydrogen bonds with the main chain atoms of residues
A26 and A28 near the N terminus. The role of the buried res-
idue corresponding to E55 has been extensively studied in
thioredoxin, and for PDI it has been suggested to facilitate
the escape of the active site from a mixed disulfide with
the substrate (LeMaster et al., 1997). Although the E55
side chain is 4.7 A˚ from the sulfur of C64, it could either di-
rectly form a hydrogen bond with this residue, if C64 adopts
a different side chain conformation, or indirectly through
a buried water molecule, as shown in thioredoxin (Menchise
et al., 2001). This interaction will facilitate deprotonation of
the sulfhydryl group and formation of the disulfide bond be-
tween C64 and C61 of the a domain. A corresponding pro-
ton transfer mechanism does not appear to exist in the
a0 domain, because E55 is replaced by L400, which could
partially explain why the active site in the a domain is more
stable in the oxidized state compared to the a0 domain. In
contrast to yeast PDI, mammalian PDIs have a Glu in the first
and Lys in the second position in the a and a0 domains (high-
lighted with black arrows in Figure 1B). The conservation ofCell 124, 61–73, January 13, 2006 ª2006 Elsevier Inc. 67
Figure 5. Active Site Features of PDI
(A) Stereo view of a SIGMAA weighted electron density map (one rms deviation contour level) near the a domain active site. The S atoms of the active site
cysteines are shown in yellow for the oxidized state and orange for the reduced state.
(B) Close-up view into the active site of the a domain. b strands are shown in yellow, a helices in green, and loops in gray. Selected residues are displayed in
stick representation, the buried water molecule as a red sphere, and hydrogen bonds as dashed lines. Only the oxidized state of the active site is displayed.
Not all secondary structure elements are shown to increase visibility, but the surface is displayed for the entire domain.
(C) Close-up view into the active site of the a0 domain.68 Cell 124, 61–73, January 13, 2006 ª2006 Elsevier Inc.
these residues might explain why the redox potentials of the
a and a0 domains in mammalian PDI are nearly indistinguish-
able (Darby and Creighton, 1995a), in contrast to yeast PDI
(Wilkinson et al., 2005).
Active Site Access
A highly conserved tryptophan located immediately before
each active site adopts different conformations in the
a and a0 domains (Figures 5B and 5C). This difference is
most likely caused by different crystal-packing environments
involving this residue, because the a domain tightly interacts
with the b domain of a symmetry-related molecule (Fig-
ure 4C). As a consequence of this interaction, W60 is well-
defined in the electron density map, whereas W405 in the
a0 domain is highly mobile and does not seem to participate
in any interaction. Furthermore, C406 in the a0 domain is
more exposed to solvent than C61 in the a domain as a con-
sequence of the conformational changes in the respective
tryptophan residue. Previous mutagenesis studies of the
corresponding tryptophan in thioredoxin have shown that
this residue can be replaced, without compromising enzyme
function, with either phenylalanine or tyrosine, but not with
alanine (Krause and Holmgren, 1991). In agreement with
these results, we detected that simultaneous replacement
of both tryptophan residues with either glutamate or lysine
substantially reduces the catalytic activity by more than
50% in the refolding of rRNase (data not shown). This obser-
vation is consistent with a role of the tryptophan in contacting
the substrate via hydrophobic interactions and acting as
a flexible shield for the active site.
Access to the active site is also facilitated by the glycine of
the C-G-H-C motif. The glycine does not display an unusual
backbone conformation, because it is located in an a helix
and correspondingly adopts torsion angles that are easily at-
tainable for other residues. Rather, the lack of a side chain
appears to allow access of substrates to the active site, in
particular to the first cysteine. The observed flexibility of the
polypeptide backbone around residues 404–406 in the
a0 domain indicates that this segment in the absence of
a substrate is rather mobile and may become ordered only
after substrate binding, which would allow accommodation
of structurally diverse molecules.
A comparison of the a and a0 domains also reveals that ac-
cess to the active site, particularly to the second cysteine of
the C-G-H-C motif from the direction roughly opposite to the
substrate binding site, differs markedly in the two domains.
In the a domain, the N terminus folds back over this part of
the surface (Figure 5D), and this conformation is stabilized
by hydrogen bonds between the side chain of Q87 and the
main chain oxygen of A26 and the main chain nitrogen ofA28. In the NMR structure of the a domain of human PDI,
the N terminus adopts a different conformation, which might
result from the replacement of Q87 with a lysine, yielding
a more solvent-accessible active site (Figure 5E). Access
to the active site in the a0 domain is completely unobstructed,
and a binding pocket can be observed in the surface repre-
sentation (Figure 5F). Previous studies have shown that Ero1
oxidizes PDI and the mixed-disulfide complex of both pro-
teins has been isolated (Frand and Kaiser, 1999). More re-
cently, it has been shown that Ero1 selectively oxidizes the
cysteine pair in the a0 domain (Tsai and Rapoport, 2002).
The crystal structure of Ero1 (Gross et al., 2004) has revealed
conformational changes in a loop harboring C100 and C105,
and these residues have been suggested to accept elec-
trons from PDI (Frand and Kaiser, 2000). Based on these
data, it is tempting to speculate that the pocket in the
a0 domain represents the binding site for the Ero1 loop con-
taining C100 and C105. This binding mode would allow PDI
to interact simultaneously with the substrate and Ero1. As
stated above, the active site of the a0 domain is more stable
in the reduced form. Following its interaction with Ero1, it will
be in the less stable oxidized state and will return to its ther-
modynamically favored reduced state by oxidizing two sulf-
hydryl groups in the substrate, thus catalyzing the net forma-
tion of disulfide bonds in the substrate.
Activity Assays
In light of the structural differences between the two active
sites, we carried out additional activity assays to detect pos-
sible differences between the active sites. By comparing the
activity of the single domain deletion mutants, abb0c and
bb0a0c (Figure 3, lines 10 and 7), it was found that deletion
of the a0 domain reduces the refolding rate of sRNase and
rRNase by 30%, whereas deletion of the a domain has
a greater effect on the refolding of rRNase (40% reduction)
than on sRNase (20% reduction). Replacements of the
second cysteine in each active site (Figure 3, lines 11 and
12) revealed that the C64A and C409A variants have similar
activities in the refolding of both substrates, with sRNase al-
ways being refolded more efficiently. Somewhat surprisingly,
the C64A variant has a lower activity in both assays com-
pared to the a domain deletion, while the C409A variant
has a lower activity in the rRNase assay than the a0 domain
deletion. This behavior can be explained by assuming that
two truncated PDI variants associate in such a way as to
mimick a functional PDI by arranging two catalytic domains
next to the substrate binding platform, which is not possible
in the point variants due to steric hindrance.
To further characterize the differences between the active
sites in PDI, two more sets of variants were analyzed. The(D) Surface representation of the a domain after a 180º rotation around the horizontal axis relative to the view in (B). The N-terminal extension covering the
pocket adjacent to the active site has not been included in the surface calculation and is shown as a magenta loop with residues 26–28 in stick represen-
tation. Hydrogen bonds are shown as dashed lines.
(E) View into the active site of the human a domain based on structure 1 of the NMR ensemble (Kemmink et al., 1996). In this and all other NMR models, the
cleft is not covered by the N-terminal extension (shown in magenta and excluded from the surface calculation).
(F) View of the yeast a0 domain highlighting the putative Ero1 binding pocket. The orientation is related to that of the a0 domain shown in (C) by a 180º rotation
around the horizontal axis.Cell 124, 61–73, January 13, 2006 ª2006 Elsevier Inc. 69
importance of the cis-peptide adjacent to the active site was
tested with the P106A and P451A and the double Pro vari-
ants (Figure 3, lines 13–15). Replacement of both prolines al-
most completely abolishes activity with either substrate. The
individual substitutions result in50% residual activity for the
a domain substitution and 25% for the a0 domain, indicat-
ing that in our assays the a0 domain makes more important
contributions to the catalytic activity. The structure of the
corresponding proline to alanine E. coli DsbA variant (Char-
bonnier et al., 1999) revealed that the cis-peptide has been
transformed into a trans-peptide, leading to significant con-
formational changes. Assuming corresponding structural
changes in the a and a0 domains of PDI in the Pro to Ala var-
iants, this will significantly affect substrate binding due to the
proximity to the active site cysteines which in turn will reduce
the reactivity of each active site. The larger contribution of the
a0 domain is also confirmed by variants in which both cyste-
ines in either the a or a0 domain were replaced with serine
(Figure 3, lines 16 and 17). The a domain substitutions
(C61S/C64S) reduce the activity to 50%, in contrast to
the C406S/C409S variant in the a0 domain with only 25%
activity remaining. A comparison of the latter with the
P451A variant shows that the relative order of the two sub-
strates is reversed, with sRNase being more active in the
C406S/C409S variant.
A final set of variants probing the roles of the second cys-
teine in each active site (Figure 3, lines 18 and 19) demon-
strates a clear difference between the two substrates. Re-
folding of sRNase works surprisingly well in the C64S/
C409S variant with 73% activity and only 17% for the
C64A/C409A variant, whereas refolding of rRNase is equally
impaired (20% remaining activity) in both variants. This
suggests that as part of the catalytic mechanism during
sRNase refolding a nucleophilic attack by the second cyste-
ine is carried out, which may still happen in the variant con-
taining serine instead of cysteine, but is impossible when the
cysteine is replaced with alanine.
Structural Homology
Formation of disulfide bonds in the E. coli periplasm requires
the soluble proteins DsbA, an oxidase, which generates di-
sulfide bonds between two cysteines; and DsbC, an isomer-
ase. Their respective redox partners, DsbB and DsbD, keep
DsbA in the oxidized and DsbC in the reduced form. Unex-
pectedly, the overall structure of PDI and DsbC reveal a strik-
ing degree of similarity. DsbC forms a homodimer (McCarthy
et al., 2000) where each subunit has an N-terminal dimeriza-
tion module followed by a thioredoxin-like domain containing
the active-site cysteines. The overall shape of the molecule
resembles the letter ‘‘V,’’ with the active sites located close
to the ends of the ‘‘V’’ and facing each other (Figure 6A).
The inside of the ‘‘V’’ is enriched in hydrophobic residues,
thus facilitating interactions with unfolded/partially folded
protein substrates (Figure 6B). Similar structural features
are also observed in DsbG (Heras et al., 2004). The overall
arrangements of both thioredoxin domains in DsbC/DsbG
and the exposed hydrophobic residues are remarkably sim-
ilar to yeast PDI. Because the domain architecture and olig-70 Cell 124, 61–73, January 13, 2006 ª2006 Elsevier Inc.omeric state of PDI and DsbC/DsbG are fundamentally dif-
ferent, this structural resemblance must be the result of
convergent evolution.
The molecular mimickry between PDI and DsbC/DsbG
provides a common functional basis for protein disulfide
isomerization. Specifically, these structures demonstrate
that two thioredoxin-like domains in close spatial proximity
on opposite sides of a large pocket are the hallmark of an ef-
ficient isomerase. Individual catalytic domains of human PDI
have a very low isomerization activity of 5% (Darby et al.,
1998), while heterodimers of DsbC with one active and one
inactive thioredoxin domain are basically inactive (Sun and
Wang, 2000). One possible explanation for this observation
could be that PDI with two active thioredoxin domains, like
the DsbC/DsbG dimer, has the ability to more or less
simultaneously reduce two incorrect disulfide bonds, which
will reduce conformational strain in the substrate and facili-
tate the correct pairing of cysteine residues. This is in contrast
to proteins with a single thioredoxin domain where the initial
incorrect disulfide bond might simply reform after some
time because the substrate is conformationally trapped by
the remaining incorrect disulfide pairs. Furthermore, the pep-
tide binding sites present in PDI and DsbC/DsbG will contrib-
ute to the isomerase activity by selecting proteins with
Figure 6. Relationship to DsbC
(A) Ribbon diagram of the DsbC dimer with the thioredoxin domains in
green, dimerization modules in orange and magenta, and connecting
helices in blue.
(B) Surface representation of DsbC viewed into the active site cleft. The
surface is color coded according to the same hydrophobicity scale uti-
lized in Figure 4A, and the active sites are labeled in red.
incorrect disulfide bonds via hydrophobic interactions, thus
increasing their local concentrations. In contrast to DsbC/
DsbG, PDI not only acts as an isomerase, but also catalyzes
disulfide bond formation through its oxidase activity.
Mammalian PDI
Based on the similarity of their primary structures and domain
boundaries, it seems likely that mammalian and yeast PDI will
share the same architecture, including the relative orientation
of the domains with the two active sites facing each other, the
continuous hydrophobic surface, and the primary substrate
binding site in the b0 domain. On the level of the individual
a and b domains, this assumption is confirmed by the close
structural resemblance between the corresponding domains
of yeast and human PDI, which can be superimposed with
rms deviations of 1.4 A˚ for 106 Ca atoms and 1.8 A˚ for 75
Ca atoms, respectively. Nevertheless, there are a few note-
worthy differences between mammalian and yeast PDI. First,
the C-terminal extension of mammalian PDI probably does
not play an important role in its activity (Darby et al., 1998; Koi-
vunen et al., 1999), while our structural and biochemical stud-
ies indicate a functional role of the C terminus. Second, the
redox potentials of the a and a0 domains in mammalian PDI
are more similar than in yeast PDI (Darby and Creighton,
1995a; Schwaller et al., 2003). The structure suggests that
conservation of the polar residues, Glu and Lys (Figure 1B),
in the vicinity of the active-site cysteines between the a and
a0 domains might be responsible for this property. However,
despite having similar redox potentials, the two active sites of
mammalian PDI were shown not to be equally efficient in cat-
alyzing the refolding of rRNase (Lyles and Gilbert, 1994), and
this difference must be caused by factors other than the re-
dox potential.
General Implications for the Catalytic Mechanism
Our structural analysis of yeast PDI, the first full-length struc-
ture of any PDI, established the existence of a continuous hy-
drophobic surface, providing the basis for substrate binding
in the context of PDI’s isomerase and oxidase activities and
its ability to act as a chaperone, because substrates of PDI
presumably feature exposed hydrophobic surfaces due to
partial misfolding. This forms the molecular basis for sub-
strate recognition by PDI, as it has been demonstrated that
unfolded proteins bind with higher affinity to PDI than native
proteins (Zheng and Gilbert, 2001). The modular architecture
of the enzyme in which two flexible catalytic domains are at-
tached to a presumably rigid substrate binding scaffold
formed by the b0 and b domains enables PDI to accommo-
date a diverse set of substrates differing in terms of size,
as well as the location and number of disulfide bonds. The
two active sites of PDI act in a concerted fashion on the sub-
strate, leading to the release of conformational strain in the
substrate. The overall process would initially be driven by
favorable interactions between solved exposed hydrophobic
residues of the misfolded substrate and the hydrophobic
surfaces of PDI, but with the gradual establishment of the
correct pattern of disulfide bonds this driving force would
eventually disappear. Even intermediates with near nativestructures such as those encountered during the folding of
BPTI (Weissman and Kim, 1991) will be in rapid equilibrium
with their unfolded states, and it is presumably those confor-
mations that are recognized by PDI and provide a starting
point for its isomerase activity.
EXPERIMENTAL PROCEDURES
Crystallization
Protein expression, purification, site-directed mutagenesis, and assays
were carried out as described in the Supplemental Data. Crystallization
was performed at 22ºC using the hanging-drop vapor diffusion method
by mixing 1 ml of protein (30 mg/ml) and 1 ml reservoir solution containing
0.1 M Na cacodylate (pH 6.5), 200–500 mM MgCl2, 28%–30% PEG 2000
MME. The resulting crystals diffracted to barely beyond 4 A˚ resolution. By
switching to 4ºC, improved crystals were obtained, which initially dif-
fracted to 3.3 A˚. However, the low temperature not only slowed down
crystallization significantly, with crystals appearing only after several
months, but also resulted in few suitable crystals. This made both further
optimization and the search for heavy-atom derivatives difficult. In addi-
tion, seleno-methionine-substituted PDI failed to crystallize at 4ºC, while
attempts to solve the structure by molecular replacement using the
NMR models of the a and b domains of human PDI and bacterial thiore-
doxins were also unsuccessful. Consequently, a variety of truncated and
‘‘surface’’ mutants of PDI were made to establish new crystallization con-
ditions. During this process, a truncated form of PDI crystallized, PDI36*,
which contains the a and b domains and a small fragment of the
b0 domain. The PDI36* structure was solved by multiwavelength anoma-
lous diffraction using seleno-methionine substituted protein (G.T. et al.,
unpublished data).
Data Collection, Structure Determination, and Refinement
Diffraction data were collected at 100 K on beamlines X25 and X26C at
the National Synchrotron Light Source at Brookhaven National Labora-
tory and on beamline 19ID at the Advanced Photon Source at Argonne
National Laboratory. All data were indexed and scaled with HKL2000
(Otwinowski and Minor, 1997). The structure of full-length PDI was solved
by molecular replacement with PDI36* as search model using a 3.3 A˚ res-
olution dataset. The isolated a and b domains were easily located with the
programs MOLREP and PHASER at 4 A˚ resolution. With the a and b do-
mains fixed, the a0 domain was identified with the a domain as search
model. Finally, the b0 domain was located manually by fitting it into a region
of significant difference density located between the a0 and b domains.
The resulting model was refined with REFMAC against the 3.3 A˚ dataset
to an Rfree of 0.37. At this point, the 2.4 A˚ dataset (Table 1) became avail-
able, which was derived from a crystal that formed after 9 months of in-
cubation at 4ºC. Refinement was completed with REFMAC, including
TLS refinement where the a, b, b0, and a0 + c domains were treated
as separate entities. Secondary structure elements were defined with
PROMOTIF (Hutchinson and Thornton, 1996), and figures were gener-
ated with Pymol (DeLano, 2002).
Supplemental Data
The Supplemental Data for this article, including Supplemental Results,
Discussion, Experimental Procedures, and a figure, can be found online
at http://www.cell.com/cgi/content/full/124/1/61/DC1/.
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